Ischemic Stroke Caused by a Hyaluronic Acid Gel Embolism Treated with Tissue Plasminogen Activator

Ischemic Stroke Caused by a Hyaluronic Acid Gel Embolism Treated with Tissue Plasminogen Activator

Bibliographic Details
Main Authors:	Sukyoon Lee, Jin-ho Jung, Junghwa Seo, Eung-Gyu Kim
Format:	Article
Language:	English
Published:	The Korean Neurocritical Care Society 2017-12-01
Series:	Journal of Neurocritical Care
Online Access:	http://www.e-jnc.org/upload/pdf/jnc-170020.pdf

Similar Items

Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
by: Sanjith Aaron, et al.
Published: (2020-12-01)

The influence of dehydration on the prognosis of acute ischemic stroke for patients treated with tissue plasminogen activator
by: Fei-Fan Wu, et al.
Published: (2017-06-01)

Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
by: Yasuhiro Suzuki
Published: (2010-01-01)

Genome response to tissue plasminogen activator in experimental ischemic stroke
by: Liu Dazhi, et al.
Published: (2010-04-01)

Association between Smoking and Functional Outcome in Acute Ischemic Stroke Population Treated with Tissue Plasminogen Activator
by: ajani, iretioluwa, et al.
Published: (2018)

The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt
by: Ahmed Farouk Donia, et al.
Published: (2017-12-01)

Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
by: Nicholas G Kounis, et al.
Published: (2011-01-01)

The Outcome of Treatment with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
by: Alia Saberi, et al.
Published: (2021-07-01)

Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke
by: Huang Dongdong, et al.
Published: (2019-09-01)

Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016-06-01)

An unusual cause of ischemic stroke - Cerebral air embolism
by: Vinit Suri, et al.
Published: (2014-01-01)

Association of Geographical Factors With Administration of Tissue Plasminogen Activator for Acute Ischemic Stroke
by: Kunisawa, Susumu
Published: (2014)

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer
by: Yukihiro Yoneda, et al.
Published: (2014-10-01)

Effect of Tissue Plasminogen Activator on Treatment Outcome and Neuronal Degeneration in Acute Ischemic Stroke
by: Muhammad Masoud, et al.
Published: (2021-01-01)

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
by: Benjamin Chaucer, et al.
Published: (2018-01-01)

A case of renal artery embolism treated by selective intra-arterial infusion of tissue plasminogen activator
by: Onur Baydar, et al.
Published: (2013-09-01)

The Pattern Analysis of Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke and Analysis Package Development
by: Shin Tyng Lee, et al.
Published: (2018)

Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator
by: Talia Knecht, et al.
Published: (2018-01-01)

Intravenous tissue plasminogen activator for ischemic stroke in early pregnancy dosed by actual body weight
by: Gary D Peksa, et al.
Published: (2019-02-01)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
by: Sadeghi-Hokmabadi E, et al.
Published: (2016-10-01)

Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment
by: Yonge Liu, et al.
Published: (2021-03-01)

Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke
by: Jay Chol Choi, et al.
Published: (2015-09-01)

Tissue Plasminogen Activator for Cortical Embolism Stroke with Magnetic Resonance Perfusion Imaging: A Report of Two Cases
by: Kenichiro Yi, et al.
Published: (2019-07-01)

Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
by: Yi-Ju Tseng, et al.
Published: (2020-01-01)

Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger
by: Adatia Sweta, et al.
Published: (2010-01-01)

Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
by: Yi Zhang, et al.
Published: (2016-01-01)

Magnetically Guided Recombinant Tissue Plasminogen Activator for Target Thrombolysis in a Rat Ischemic Stroke Model
by: Hsiao Pin Lin, et al.
Published: (2009)

Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.
by: Ryu Matsuo, et al.
Published: (2014-01-01)

Functional Outcome Measures of Recombinant Tissue Plasminogen Activator–Treated Stroke Patients in the Telestroke Technology
by: Jordan Gainey, et al.
Published: (2018-09-01)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
by: Sharma S, et al.
Published: (2008-01-01)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
by: Chapman SN, et al.
Published: (2014-02-01)

A case of tongue swelling after intravenous recombinant tissue plasminogen activator administration for acute ischemic stroke
by: Murat Cabalar, et al.
Published: (2017-08-01)

Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection
by: Priyank Khandelwal, et al.
Published: (2021-01-01)

Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
by: Vishal Gulati
Published: (2018-01-01)

Altered Gene Expression in an Embolic Stroke Model After Thrombolysis With Tissue Plasminogen Activator and Stachybotrys microspora Triprenyl Phenol-7
by: Terumasa Hashimoto, et al.
Published: (2014-01-01)

The Early Outcomes of Nurse Case Management in Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator: A Prospective Randomized Controlled Trial
by: Urai Kummarg, et al.
Published: (2018-01-01)

Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism -A case report-
by: Min Soo Kim, et al.
Published: (2010-07-01)

Cost-effectiveness Analysis of Tissue Plasminogen Activator for Acute Ischemic Stroke in National Taiwan University Hospital Hsinchu Branch
by: Chou,Ping-Chen, et al.
Published: (2013)

A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke
by: Run-Hao Jiang, et al.
Published: (2019-06-01)

Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats.
by: Kunio Kawamura, et al.
Published: (2014-01-01)